Health Canada conducted only 15% of site inspections as it leaned on foreign regulators for oversight
Hims & Hers targets 2026 launch as Novo Nordisk's semaglutide patent nears January expiry
Canada's $7 billion drug exports face risk as Trump signals steep tariffs and pricing reform crackdown
New PMPRB rules restrict who can trigger reviews and shift focus to inflation and global price gaps
Canadian trial finds common medicine may aid memory in Parkinson's-related dementia cases
GreenShield's Essential Medicines program targets Canadians without coverage, offering up to $1,000 in drug support
